PAR-20-225 - Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Active NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)
Notice of Special Interest (NOSI): Targeting the Endocannabinoid System for Brain Health and Acute and Chronic Diseases NOT-DA-22-048 NIDA , NCI , NIDCR Jan 9, 2023 Jan 8, 2026 R01, R21, DP2, DP1, K99/R00, K01, R36, K08, R15, K24

Expired NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)


Technical Issues: E-mail OER Webmaster